Core Viewpoint - The AI Fund ICBC Healthcare Stock (000831) reported a profit of 209 million yuan for Q1 2025, with a weighted average profit per fund share of 0.1864 yuan, indicating a net value growth rate of 8.25% during the reporting period [3]. Fund Performance - As of April 24, the fund's unit net value was 2.502 yuan, with a three-month net value growth rate of 11.10%, ranking 32 out of 54 comparable funds [4]. - The fund's six-month net value growth rate was 4.38%, ranking 25 out of 54, while the one-year growth rate was 1.54%, ranking 37 out of 54 [4]. - Over the past three years, the fund's net value growth rate was -13.87%, ranking 22 out of 46 [4]. Risk Metrics - The fund's Sharpe ratio over the past three years was -0.0859, ranking 20 out of 44 comparable funds [10]. - The maximum drawdown over the past three years was 40.75%, with the largest single-quarter drawdown occurring in Q3 2022 at 24.01% [12]. Fund Holdings and Strategy - As of Q1 2025, the fund's total assets amounted to 2.724 billion yuan [16]. - The top ten holdings included companies such as Heng Rui Medicine, WuXi AppTec, and Mindray Medical, indicating a focus on leading firms in the healthcare sector [18]. - The fund manager noted a stabilization trend in consumer medical demand, with a cautious outlook on whether this trend can sustain or improve [3]. Long-term optimism remains for advancements in refractive surgery technology, increased penetration in myopia prevention, and growth in dental implants and medical aesthetics [3].
工银医疗保健股票：2025年第一季度利润2.09亿元 净值增长率8.25%
Sou Hu Cai Jing·2025-05-03 12:41